RN7SL783P

Across TCGA pan-cancer cohorts, RN7SL783P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RN7SL783P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RN7SL783P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL783P expression acts as an unfavorable survival marker, although some lineages such as SKCM and STAD show a favorable association.

BLCA, PAAD, and OV are the cancer types where RN7SL783P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	III,IV	0.201	0.554	<.001	63	view →
PAAD	DFS	Tertile	All	0.117	0.488	<.001	63	view →
OV	DFS	Tertile	All	0.104	0.172	.012	48	view →
SKCM	DFS	Tertile	II,III,IV	0.733	0.238	.002	45	view →
UCEC	DFS	Tertile	All	0.265	0.660	.006	30	view →
ACC	OS	Tertile	IV	0.251	0.743	<.001	18	view →
STAD	OS	Quartile	IV	0.672	0.263	.014	18	view →
READ	OS	Tertile	II,III,IV	0.287	0.829	.031	18	view →
LGG	OS	Tertile	All	0.885	0.907	.042	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RN7SL783P–BLCA (DFS)

Open the BLCA breakdown →